Description

Synthetic melanocortin receptor agonist studied in research models exploring MC1R and MC4R signaling pathways related to pigmentation biology and neuroendocrine modulation.

Example Research Protocol Range (Standardized)
250–1000 mcg per administration; frequency varies by model; study windows commonly 2–8 weeks (model-dependent).

More Information
Commonly studied in melanocortin receptor signaling research, pigmentation pathway models, neuroendocrine-axis investigations, and energy-regulation signaling studies.

PDP Short (Consumer-Friendly, RUO)
A research-grade melanocortin receptor agonist designed for laboratories investigating pigmentation and neuroendocrine signaling pathways.

PDP Long (Consumer-Friendly, RUO)
Melanotan II is a research-use–only melanocortin receptor agonist selected for laboratories studying MC1R and MC4R signaling pathways. Frequently explored in pigmentation biology models and neuroendocrine-axis investigations, this compound supports structured research cycles examining receptor-mediated pathway dynamics. Brava Longevity provides a premium, lyophilized format intended exclusively for qualified research environments.For Research Use Only (RUO). Not for human or veterinary use. Not a drug. Not intended to diagnose, treat, cure, or prevent any disease.